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In the present work, a large scale investigation was
done regarding the capacity of cultured human cell
lines (carrying in homoplasmic form either the mito-
chondrial tRNALys A8344G mutation associated with the
myoclonic epilepsy and ragged red fiber (MERRF) en-
cephalomyopathy or a frameshift mutation, isolated in
vitro, in the gene for the ND4 subunit of NADH dehydro-
genase) to undergo transcomplementation of their re-
cessive mitochondrial DNA (mtDNA) mutations after
cell fusion. The presence of appropriate nuclear drug
resistance markers in the two cell lines allowed meas-
urements of the frequency of cell fusion in glucose-con-
taining medium, non-selective for respiratory capacity,
whereas the frequency of transcomplementation of the
two mtDNA mutations was determined by growing the
same cell fusion mixture in galactose-containing
medium, selective for respiratory competence.
Transcomplementation of the two mutations was re-
vealed by the re-establishment of normal mitochondrial
protein synthesis and respiratory activity and by the
relative rates synthesis of two isoforms of the ND3 sub-
unit of NADH dehydrogenase. The results of several ex-
periments showed a cell fusion frequency between 1.4
and 3.4% and an absolute transcomplementation fre-
quency that varied between 1.2 3 1025 and 5.5 3 1024.
Thus, only 0.3–1.6% of the fusion products exhibited
transcomplementation of the two mutations. These rare
transcomplementing clones were very sluggish in devel-
oping, grew very slowly thereafter, and showed a sub-
stantial rate of cell death (22–28%). The present results
strongly support the conclusion that the capacity of mi-
tochondria to fuse and mix their contents is not a gen-
eral intrinsic property of these organelles in mamma-
lian cells, although it may become activated in some
developmental or physiological situations.
The compartmentalization of mitochondrial DNA (mtDNA)1
in distinct organelles and the changes in the distribution of the
mitochondrial genome in a cell brought about by mitochondrial
growth, division, and movement and, in some cells, by mito-
chondria fusion account for the fact that the organization of
these organelles plays a critical role in determining the segre-
gation and complementation behavior of wild-type and mutant
mtDNA, when they co-exist in a cell.
In simpler eukaryotic cells, like Saccharomyces cerevisiae (1,
2), Chlamydomonas species (3) and slime mold (4), and in plants
(5, 6), there is ample evidence of mtDNA complementation and
recombination, which is made possible by the well established
capacity of mitochondria to undergo fusion in these organisms.
These fusion events are genetically regulated (2, 4, 7). In animal
cells, studies using time-lapse bright-field, phase-contrast, inter-
ference and fluorescence microscopy and electron microscopy of
serial sections have revealed in some cell types a mitochondrial
organization in the form of a network of interconnected tubular
organelles, with suggestion of fusion events (8–11). Recently, the
occurrence of a developmentally regulated fusion of mitochondria
in postmeiotic spermatids of Drosophila melanogaster, which is
mediated by the transient synthesis of a novel GTPase encoded
in the fuzzy onions (fzo) gene, has been described (12). Homologs
of this gene have been found in mammals, nematodes, and S.
cerevisiae (12–14). However, mitochondria of mammalian sper-
matids have been reported not to fuse but to form structurally
distinct contacts (15). Similar contacts have also been described
in rat cardiac tissue (16). A developmentally regulated formation
of a reticulum of tightly joined mitochondria has been reported
for rat diaphragm muscle (17).
Observations on cultured human cells have so far failed to
provide an unambiguous picture of the extent of mtDNA inter-
actions in these cells. In investigations carried out in this
laboratory (18), two mtDNAs, each carrying a recessive muta-
tion in a different mitochondrial tRNA gene, i.e. the tRNALys
gene mutation associated with the myclonic epilepsy and
ragged red fiber (MERRF) encephalomyopathy (19) and the
tRNALeu(UUR) gene mutation associated with the mitochondrial
myopathy, encephalopathy, lactic acidosis, and stroke-like ep-
isodes (MELAS) encephalomyopathy (20, 21), were independ-
ently introduced into the same human mtDNA-less (r0) cell
(143B.r0206) by enucleated cell (cytoplast) 3 r0 cell fusion (22).
After growing the fusion products under conditions non-selec-
tive for respiratory competence, no evidence of transcomple-
mentation of the mutations was found in five clones carrying
both types of parental mtDNA, even 3 months after cell fusion.
Other investigators, analyzing by fluorescence microscopy the
fusion products of enucleated wild-type human cells and hu-
man r0 cells, obtained results that were interpreted to indicate
the occurrence of a rapid and extensive fusion of host and
exogenous mitochondria and subsequent rapid diffusion of
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mtDNA and its transcripts throughout the organelles (23).
More recently, the same investigators (24, 25), after construct-
ing cybrids carrying two types of mtDNA with appropriate
markers within distinct organelles and culturing them under
conditions either selective or non-selective for recovery of res-
piratory capacity, isolated a few clones that showed evidence of
translational complementation.
In the present work, in order to obtain a more conclusive
answer to the question of the genetic autonomy of mitochondria
in cultured human cells, large scale fusion experiments were
carried out between cells and cytoplasts (or cells) carrying
different recessive mtDNA mutations, in particular either the
tRNALys MERRF mutation (26) or a frameshift mutation in the
NADH dehydrogenase ND4 subunit gene (27). The determina-
tion of both the efficiency of cell fusion and the frequency of
transcomplementation between the two mutations showed un-
ambiguously that events of intergenomic complementation did
occur, but only very rarely and sluggishly in cells carrying both
parental mtDNAs, with evidence of slow growth and significant
cell death of the cell fusion products.
EXPERIMENTAL PROCEDURES
Cell Lines and Media—The pT1 human cell line, carrying in nearly
homoplasmic form the A to G transition at position 8,344 in the mito-
chondrial tRNALys gene, which is associated with the MERRF syn-
drome (19), and the C4T cell line, carrying in homoplasmic form a
cytidine insertion in a stretch of six Cs at positions 10,947 to 10,952 in
the mitochondrial ND4 gene (27), had been previously isolated by
transfer into human mtDNA-less 143B.r0206 cells of mitochondria from
myoblasts of a MERRF patient (26) and, respectively, from a mutant of
the VA2B human cell line (27) by cytoplast 3 cell fusion. They were
grown in Dulbecco’s modified Eagle’s medium (DMEM), supplemented
with 5% dialyzed fetal calf serum (FCS) and 100 mg of bromodeoxyuri-
dine (BrdUrd) per ml. The parental line of r0206, 143B.TK2 (22) was
grown in DMEM with 5% FCS and 100 mg of BrdUrd per ml. The r013.1
cell line, a mtDNA-less derivative of an adenine phosphoribosyltrans-
ferase (APRTase)-less mutant of 143B.TK2 (26) was grown in DMEM
supplemented with 5% FCS and containing 50 mg of uridine, 100 mg of
BrdUrd, and 50 mg of 8-azadenine per ml. Transformants of the r013.1
cell line, obtained by cytoplast 3 cell fusion-mediated transfer of mito-
chondria from C4T cells (hereafter designated C4.13-E, -I, or -J), were
grown in DMEM supplemented with 5% dialyzed FCS, 100 mg of Br-
dUrd, and 50 mg of 8-azadenine per ml (26). The population doubling
times of the various cell lines were determined as described previously
(29).
Isolation of Double Transformants—Unless other conditions are in-
dicated, 1–5 3 105 cells of the chosen mitochondrial donor cell line were
enucleated by centrifugation in the presence of cytochalasin B, and the
predominantly enucleated cells were then fused, using polyethylene
glycol 1500 (PEG), with 1–5 3 105 cells of the chosen recipient cell line,
as described previously (30). After 1–6 days of incubation, as specified
below, in non-selective medium, double transformants carrying both
the MERRF tRNALys gene 8344 mutation and the ND4 frameshift
mutation were selected and thereafter grown in “special DMEM/galac-
tose” medium. This medium contained 0.9 mg/ml galactose instead of
glucose and 0.50 mg/ml pyruvate (28) and was supplemented with 10%
dialyzed FCS, 100 mg of BrdUrd per ml, and, when C4.13-E, or -I, or -J
were used as recipient cells, also with 50 mg of 8-azaadenine per ml.
Colonies were recognized between 3 and 4 weeks after plating, and
those that appeared healthy were picked up for analysis.
Karyotype Determination—Karyotype determination was done, as
described previously (31), in cells arrested in metaphase by treatment
with 0.5 mg of colchicine per ml for 3 h.
DNA Analysis—Total DNA was isolated from cells as described pre-
viously (32). Quantification of mtDNA mutations was carried out in
most cases by allele-specific termination of primer extension (33, 34).
For this purpose, a 346-base pair mtDNA segment between positions
10,762 and 11,108, containing the ND4 mutation, and a 173-base pair
segment between positions 8191 and 8364 of mtDNA, containing the
MERRF tRNALys mutation, were amplified with Taq polymerase. The
two amplified fragments were separated from free nucleotides on a Tris
borate/EDTA, 1.5% agarose gel, and eluted from the gel by the QIAEX
II gel extraction kit (Qiagen). Then each amplified product was used for
allele-specific primer extension termination, using Sequenase (Amer-
sham Pharmacia Biotech) and the corresponding 32P-59-end-labeled
primer (33, 34). Nucleotide concentrations were 33 mM dGTP and 500
mM ddTTP for the quantification of the C insertion in the ND4 gene, and
33 mM TTP, 33 mM dGTP, and 500 mM ddCTP for the quantification of
the mutation in the tRNALys gene. The mixtures were heated to 95 °C
for 3 min and annealed at 50 °C for 10 min. After addition of Sequenase,
they were incubated for 6 min at 45 °C. Electrophoretic analysis of the
products and quantification of the intensity of the bands were carried
out as described previously (33, 34). In some experiments, quantifica-
tion of the MERRF mutation was carried out by NaeI restriction en-
zyme digestion of a mtDNA segment that had been amplified by polym-
erase chain reaction, using a mismatched primer generating a new NaeI
site (18).
Mitochondrial Protein Synthesis and O2 Consumption Analysis—The
cultures were labeled with [35S]methionine (.800 Ci/mmol, 25 mCi/ml)
for 2 h in the presence of 100 mg of emetine per ml, and translation
products were electrophoresed as described previously (26). O2 con-
sumption measurements were made as detailed earlier (22).
RESULTS
Characterization of Parental Cell Lines—To verify the ho-
moplasmic nature of the tRNALys gene mutation in the pT1
human cell line and of the ND4 gene mutation in the C4T cell
line (see “Experimental Procedures”), allele-specific primer ex-
tension experiments were carried out, using a previously de-
scribed protocol for ND4 (33) and a protocol illustrated sche-
matically in Fig. 1a for the tRNALys gene (34). As shown in Fig.
1b, the two mutations appear to be homoplasmic. The MERRF
mutation in pT1 has been shown to produce a defect in the
aminoacylation of the mitochondrial tRNALys, which causes a
severe impairment of protein synthesis due to premature ter-
mination of translation (35). This results in an almost complete
loss of synthesis of the largest polypeptides (ND5, ND4, and
CYTb) (Fig. 1c) and the accumulation of premature translation
termination products, prominent among which are pMERRF, a
truncated COI product, and a truncated ND2 product (indicat-
ed by small arrows in Fig. 1c). The frameshift mutation in C4T
causes a complete loss of synthesis of ND4, with resulting lack
of assembly of the membrane arm of the NADH dehydrogenase
and loss of enzyme activity (27). As shown in Table I, in both
the pT1 and C4T cell lines, as a result of their mtDNA muta-
tions, O2 consumption is dramatically decreased to a level close
to that previously observed in 143B.r0206 cells (22).
Selective Conditions for Full mtDNA Functionality—For a
large scale screening of transcomplementing clones among mi-
tochondrial cybrids and hybrids containing two types of mito-
chondria carrying either the tRNALys or the ND4 gene muta-
tion, a medium containing galactose instead of glucose, which
was capable of selecting against the two parental defective cell
lines, was used. Such type of medium has been previously
shown to curtail severely the growth of cells deficient in oxida-
tive metabolism (28, 36–40).
As shown in Table I, cells carrying wild-type mtDNA
(143B.TK2 (22)) and the mutant C4T and pT1 cell lines grew
well in regular DMEM containing glucose and supplemented
with 5% FCS. When glucose was substituted by galactose, the
cells carrying wild-type mtDNA (143B.TK2) continued to grow,
although at a reduced rate, whereas both types of mutant cell
lines not only stopped growing but showed extensive cell death.
This death was indicated by the progressive cell detachment
from the plates. To confirm that the normal expression of
mtDNA was absolutely required for the survival and growth of
the 143B.TK2 cells in special DMEM/galactose medium, as
suggested by the results described above, mitochondrial pro-
tein synthesis was specifically inhibited by adding 40 mg/ml
chloramphenicol (CAP) to the incubation medium; further-
more, the medium was supplemented with 50 mg/ml uridine,
since it is known that cells without full mitochondrial gene
expression become auxotrophic for pyrimidines (22, 36, 41).
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143B.TK2 cells grew well in the presence of CAP in glucose-
containing medium supplemented with uridine but stopped
growing and became detached from the plate in special DMEM/
galactose supplemented with CAP and uridine (data not
shown).
Evidence of Reciprocal Complementation of tRNALys and
ND4 Mutations in Double Transformants—Advantage was
taken of the selective pressure provided by growth in special
DMEM/galactose medium in order to isolate clones exhibiting
transcomplementation of the tRNALys and ND4 gene muta-
tions. For this purpose, 105 pT1 cells were subjected to enucle-
ation (22), and the predominantly enucleated cells were then
fused with 5 3 105 C4T cells. After a 2-day incubation in
non-selective medium, a portion of the fusion mixture, corre-
sponding to 2.5 3 105 recipient cells, was transferred to special
DMEM/galactose medium in a Petri dish. After 3–4 weeks,
eight clones were detected. Two of them subsequently died, and
the other six were picked up. However, of them, only three (T3,
T6, and T7) kept growing and were utilized for further analysis
(Table I and Fig. 1). An equivalent portion of the fusion mixture
was transferred to special DMEM/galactose medium after a
6-day incubation in non-selective medium and yielded initially
six clones which, however, were not picked up for further
growth.
Primer extension experiments revealed that all three clones
contained both the mtDNA carrying the A8344G MERRF mu-
tation and the mtDNA carrying the ND4 mutation (Fig. 1b),
with the former one being strongly predominant. A quantifica-
tion by PhosphorImage analysis showed that the proportion of
the tRNALys mutation-carrying mtDNA varied between 71 and
;88% and that of the ND4 mutation-carrying mtDNA between
10.5 and ;22% of the total mtDNA, and that the two mutant
types of mtDNA accounted for all mtDNA, within experimental
error (Table I). The latter observation indicated that these
clones did not contain any significant amount of residual wild-
type mtDNA from either parental cell line. Furthermore, the
proportion of wild-type tRNALys genes present in ND4 gene
mutation-carrying mtDNA exceeded the minimum previously
shown to be able to complement the MERRF mutation (;10%)
(18). Therefore, one expected that, if there was complete mixing
of the gene products in the three clones, there would be full
complementation of the MERRF mutation. There are no data
on the quantitative effects of a null mutation in the ND4 genes
on their expression. However, if the same pattern of control
applies to these genes as recently observed for the human ND5
genes (42), one would expect in the three clones between 70 and
90% of the normal rate of synthesis of the ND4 protein.
The analysis of mitochondrial protein synthesis in the three
isolated clones fully confirmed the predictions mentioned
above. In fact, as shown in Fig. 1c, the three clones exhibited a
FIG. 1. Amounts of wild-type (WT) and mutant (MT) tRNALys and ND4 genes and patterns of mitochondrial translation products
in the pT1 and C4T cell lines and in three transcomplementing clones derived from the enpT1xrecC4T cell fusion experiments. a,
scheme showing the principle of the sequence-dependent termination of primer extension to quantify the A8344G transition in the mitochondrial
tRNALys gene. The same approach was used to quantify the ND4 gene mutation (33). b, fluorogram, after electrophoresis through a sequencing gel,
of the 32P-59-end-labeled primer extension products obtained from samples of total cellular DNA purified from the indicated cell lines. The
separation of the mutant and the wild-type versions of the tRNALys gene, as well as of the ND4 gene, is clearly illustrated. The relative proportions
of the two mutant mtDNAs are shown in Table I. c, fluorogram, after electrophoresis through an SDS-polyacrylamide gradient gel, of the
mitochondrial translation products of pT1 and C4T cells and of three transcomplementing clones, labeled with [35S]methionine for 2 h in the
presence of emetine. COI, COII, and COIII, subunits I, II, and III of cytochrome c oxidase; ND1 ND2, ND3, ND4, ND4L, ND5, and ND6, subunits
1, 2, 3, 4, 4L, 5, and 6 of the respiratory chain NADH dehydrogenase; A6 and A8, subunits 6 and 8 of H1-ATPase; Cyt b, apocytochrome b. The small
arrows indicate premature translation termination products characteristic of the pT1 cells, and the large arrowheads indicate the two polymorphic
variants (ND3 and ND39) of the ND3 polypeptide.
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near to normal rate of ND5, ND4, and CYTb polypeptide syn-
thesis. Furthermore, there was no clear evidence of premature
translation termination, with the exception of a small amount
of the main premature translation termination product,
pMERRF (35), migrating just ahead of ND4 in T6. The occur-
rence in C4T mtDNA, as in the VA2B parental cell mtDNA, of
an ND3 polymorphism previously described in HeLa cells,
which causes a faster migration of this subunit in a polyacryl-
amide gel (43), offered an additional useful marker of
transcomplementation. Thus, in the protein synthesis patterns
of Fig. 1c, the relative labeling of the ND3 and ND39 bands,
characteristic of pT1 and C4T mtDNA, respectively, showed a
strong prevalence of ND3 in clones T3 and T6 and nearly equal
labeling of the two bands in T7. Considering the large excess of
MERRF mutation-carrying mtDNA in the three transformants
and the expected low rate of ND3 synthesis in homoplasmic
MERRF mutant cells relative to the wild-type cells (;35%
(35)), the observed high ratio of ND3 to ND39 labeling in T3 and
T6 is consistent with a substantial level of transcomplementa-
tion in these clones of the tRNALys mutation by ND4 mutation-
carrying mtDNA.
Chromosome count in the three clones showed that T7 had
an average chromosome number very similar to those of the
parental cell lines, as expected for cybrids, whereas T3 and T6
had a chromosome number nearly double, strongly suggesting
that these two clones represented cell hybrids (Table I). Oxygen
consumption measurements (Table I) showed a recovery of the
normal rate in all three clones, when compared with the rate
expected in 143B cells (5–6 fmol/min/cell (18, 44)), in agree-
ment with the conclusion that a reciprocal complementation of
the two mutations had occurred in them. The calculated abso-
lute frequency of transcomplementation in this experiment was
thus ;1.2 3 1025 (Table II). However, a surprising finding was
that the three clones grew in regular DMEM considerably more
slowly than 143B cells (Table I). Also in special DMEM/galac-
tose medium, they grew more slowly than 143B cells (Table I).
Furthermore, in the latter medium, they showed evidence of a
significant rate of cell death, as revealed by the detachment of
cells from the plate (Table I). It was particularly intriguing that
these clones kept growing at a low rate and exhibited an ab-
normally high rate of cell death even after 18 weeks of contin-
uous culturing since their isolation.
Residual Wild-type mtDNA in the Parental pT1 Cell Line—
The very low frequency of transcomplementing clones in the
experiments described above raised the possibility that the pT1
cell line and/or the C4T cell line contained a very minor residue
of wild-type mtDNA, not detectable by the primer extension
assays, and distributed in a non-uniform way among the cells.
Rare cells in one or the other parental cell line might conceiv-
ably produce, by intramitochondrial complementation of the
mutation, clones mimicking true transcomplementing clones.
To exclude this possibility, 107 C4T cells were maintained for 6
weeks in special DMEM/galactose medium. As expected, mas-
sive cell death was observed, but not a single C4T clone able to
grow in galactose medium was detected. A similar experiment
carried out with pT1 cells also revealed a massive cell death.
Surprisingly, however, surviving clones were detected, at a
very low frequency, i.e. of ;2 per 105 original cells. In order to
investigate further this phenomenon, eight of the surviving
clones were isolated, and their mtDNA was analyzed. In all
cases, these clones were found to carry the MERRF mutation in
heteroplasmic form (Fig. 2a), exhibiting a minimum of 9%
wild-type mtDNA, which was sufficient to restore mtDNA func-
tionality in MERRF mutation-carrying cells (18).
In order to analyze the distribution of the residual wild-type
mtDNA in the MERRF mutant cell population, 10 clones were
isolated from this population in regular DMEM medium, and
106 cells of each clone were plated in special DMEM/galactose
medium. As shown in Fig. 2b, the frequency of the subclones
growing in this medium varied greatly among the original 10
pT1 clones, with the cumulative frequency (2.4 3 1025) being
very similar to that observed in the original cell population (2 3
1025). The experiment described above allowed the isolation of
pT1 clones carrying the MERRF mutation in reliably ho-
moplasmic form, as judged from the fact that 106 of their cells
did not generate any surviving subclones under strictly selec-
tive conditions. This conclusion was confirmed for clone 3 by an
experiment in which 107 cells were replated in special DMEM/
galactose, and no surviving cells were detected after 5 weeks of
culture. As expected, this clone had maintained the respirato-
ry-deficient phenotype of the pT1 cell line (Table I). Clone 3
(hereafter designated pT1.C3) was therefore chosen for all sub-
sequent experiments.
Role of the Nuclear Background in Transcomplementa-
TABLE I
Mitochondrial genotype, chromosome number, oxygen consumption rate, and doubling time of different cell lines
Cell line
Mitochondrial genotype Chromosome number
(mean 6 S.E.)
O2 consumption
rate
Doubling time
% tRNALys MT % ND4 MT Glucose Galactose
fmol/min/cell h
143B.TK2 0 0 54 5–6
b 21 46
C4T 0 100 56.3 6 1.3 0.56 29 NGd
C4.13-J 0 100 57.7 6 1.2 0.45 32 NG
C4.13-I 0 100 0.32 NG
pT1 100 0 55.0 6 2.2 0.36 26 NG
pT1.C3 100 0 54.7 6 1.1 0.44 24 NG
T3 87.7 6 1.8a 10.5 6 0.2a 100 to 110 6.4 51 78 (22%)c
T6 85.9 6 3.0a 11.2 6 1.6a 100 to 110 4.8 76 197 (28%)c
T7 71.0 6 2.6a 22.3 6 3.1a 61.2 6 2.0 7.8 48 79 (23%)c
F31 61 40 60.0 6 2.8 4.8 54
F34 79 24 106.3 6 9.4 7.1 63
F35 61 40 109.5 6 3.5 7.4 90
F39 76 24 106.0 6 12.3 7.8 61
F310 81.0 19 81.0 6 5.8 6.2 65
FJ1 71 30 56.3 6 2.2 6.5 130
FJ2 60 41 64.2 6 5.8 4.8 47
FJ3 82 18 54.7 6 2.7 4.6 135
FI1 67 34 62.8 6 9.8 8.0
a Mean 6 S.E.
b From Refs. 18 and 44.
c Numbers in parentheses represent proportion of dead (floating) cells.
d NG, no growth.
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tion—In the transcomplementation experiment described
above, a surprising finding was that in the transcomplement-
ing clones, including the cybrid T7, the MERRF mutation-
containing mtDNA was in large excess over the mtDNA carry-
ing the ND4 gene frameshift mutation. In order to test the
possible role of the nuclear background in this phenomenon, as
well as explaining the low frequency of transcomplementation,
another cell fusion experiment was carried out, this time using
5 3 105 predominantly enucleated C4T cells as mitochondria
donors and 5 3 105 pT1.C3 cells as recipients. The use of the
pT1.C3 cells was also expected to provide a test of the possible
influence of the small amount of endogenous wild-type tRNALys
genes in the previous experiment. A portion of the fusion mix-
ture, corresponding to ;1.7 3 105 recipient pT1.C3 cells, after
24 h incubation in non-selective medium, was transferred to
special DMEM/galactose in two 10-cm dishes. Of 31 detected
clones, only 10 continued to grow, and among these, five clones
(F31, F34, F35, F39, and F310) were randomly selected for
further analysis.
Primer extension analysis revealed that all five clones con-
tained both the MERRF mutation-carrying mtDNA and the
ND4 mutation-carrying mtDNA (Fig. 3), with the former being
again predominant, although somewhat less than in the first
experiment (Table I). The ND4 mutation-carrying mtDNA,
with the MERRF-mutant mtDNA, again accounted, within
6,3%, for the total mtDNA (Table I). Karyotype analysis
indicated the likely cybrid nature of the F31 and F310 clones,
with an increased parental chromosome number, and the prob-
able hybrid nature of the F34, F35, and F39 clones (Table I).
As observed for the clones isolated in the first experiment,
the new five selected clones grew very slowly in special DMEM/
galactose medium (Table I), again with evidence of a significant
rate of cell death as revealed by cell detachment from the plates
(data not shown). The recovery of mtDNA functionality in these
clones was indicated by the re-establishment of full respiratory
capacity (Table I) and of a nearly normal mitochondrial protein
synthesis pattern, as well as by the substantial reduction of the
premature translation termination products pMERRF and
truncated ND2 polypeptide and by the relatively high rate of
labeling of the ND3 subunit. These results indicated that
transcomplementation of the two mutations had occurred in
these clones, although the evidence suggested a less effective
TABLE II
Summary of the transcomplementation experiments
Expt. Enucleated cells Recipient cells
Glucose medium Galactose medium
Relative
complementation
frequencyeClonesanalyzed
Clones
with
both
genomes
Fusion
frequencya
Recipient
cells plated
Maximum
clones
expectedb
Surviving
clonesc
Absolute
complementation
frequencyd
1 pT1 (105) C4T (5 3 105) 2.5 3 105 3 (8) 1.2 3 1025
2 C4T (5 3 105) pT1.C3 (5 3 105) 1.67 3 105 10 (31) 6.0 3 1025
3 pT1.C3 (5 3 105) C4.13-E (5 3 105) 144 4 0.028 1.67 3 105 4639 14 (35) 8.4 3 1025 3.0 3 1023
4 pT1.C3 (5 3 105) C4.13-J (5 3 105) 212 3 0.014 1.67 3 105 2363 9 5.4 3 1025 3.8 3 1023
5 pT1.C3 (5 3 105) C4.13-J (5 3 105) 140 0 1.67 3 105 3 1.8 3 1025
6 pT1.C3 (5 3 105) C4.13-I (5 3 105) 140 0 1.67 3 105 2 1.2 3 1025
7 pT1.C3 (5 3 105) C4.13-J (105) 160 0 3.33 3 104 1 3.0 3 1025
8 pT1.C3 (5 3 105) C4.13-J (2 3 104) 88 3 0.34 2.00 3 104 682 11 5.5 3 1024 16.1 3 1023
a Determined from the ratio of the number of clones with both genomes to the number of clones analyzed.
b Values calculated assuming that transcomplementation would occur in all fusion products.
c The values in parentheses indicate the total number of clones originally detected, some of which subsequently died.
d Determined from the ratio of surviving clones to the number of recipient cells plated.
e Determined from the ratio of absolute complementation frequency to fusion frequency.
FIG. 2. Evidence of the presence of a
residual minor amount of wild-type
(WT) mtDNA in pT1 cells. a, shows a
fluorogram, after electrophoresis through
a sequencing gel, of the 32P-59-end-labeled
primer extension products obtained from
samples of total cellular DNA extracted
from the parental pT1 and C4T cell lines
and eight pT1 clones able to grow in ga-
lactose-containing medium. b, the yield of
subclones growing in galactose-contain-
ing medium from 106 cell samples of 10
independent clones isolated in glucose-
containing medium from the original pT1
cell line is compared with the yield ob-
tained from the original pT1 cell popula-
tion. Mean indicates the average yield of
subclones from the 10 clones 6 S.E.
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expression of the C4T mtDNA than in the previous experiment.
The calculated absolute complementation frequency was ;6 3
1025, i.e. considerably higher than that measured in the first
experiment (Table II), presumably reflecting the higher ratio of
mitochondrial donor to recipient cells used in the cell fusion. In
conclusion, the results obtained in this experiment, which uti-
lized pT1.C3 cells as recipients, showed that the small residue
of wild-type mtDNA in pT1 cells was not responsible for the
transcomplementation observed in the previous experiment.
Furthermore, they indicated that the nuclear background of
the recipient cells did not play any significant role in the
predominance of the MERRF mutation-carrying mtDNA in the
transcomplementing clones.
Frequency of Transcomplementation Relative to Cell Fusion
Frequency—A critical factor in evaluating the significance of
the low absolute frequency of transcomplementation in the
experiments described in the previous sections was the effi-
ciency of cytoplast or cell 3 cell fusion. In order to estimate the
frequency of the fusion events, growth of the products under
conditions non-selective for respiration competence, i.e. in reg-
ular glucose-containing DMEM, was required. The quantifica-
tion in this type of experiment, in turn, was expected to be
greatly facilitated by the elimination from the mitochondrial
donors, in this case pT1.C3 cells, of non-enucleated cells. These,
in fact, could grow in medium non-selective for respiration
competence and thus interfere with the identification of the
A8344G mutation-carrying mtDNA in the cybrids or hybrids, to
be carried out by NaeI digestion of total cell DNA (see “Exper-
imental Procedures”). In order to eliminate the non-enucleated
mitochondrial donor cells, a C4T derivative carrying a second
drug resistance marker, besides BrdUrd resistance, was iso-
lated. For this purpose, the ND4 mutation-carrying mitochon-
dria were transferred, as detailed under “Experimental Proce-
dures,” into a cell line different from 143B.r0206, i.e.
143B.r013.1. This cell line had been previously isolated by long
term exposure to a low concentration of ethidium bromide of an
APRTase-less mutant, which was, therefore, resistant to
8-azaadenine, of 143B.TK2 cells (26). Several clones resistant
to BrdUrd and 8-azaadenine were thus isolated, and three of
these (C4.13E, C4.13J, and C4.13I) were utilized as recipients
for fusion with enucleated pT1.C3 cells in subsequent experi-
ments. It was verified that they contained pure mutant ND4
gene and had a respiratory-deficient phenotype, as shown for
clones C4.13J and C4.13I in Fig. 3 and Table I.
Several fusions between C4.13 clones and enucleated pT1.C3
cells were carried out, as detailed in Table II. In two experi-
ments (experiments 7 and 8), a 5-fold and, respectively, 25-fold
higher ratio of cytoplasts to recipient cells was used, as com-
pared with the other experiments. In each case, after 24 h
incubation in non-selective medium, a portion of the fusion
mixture was plated in an appropriate number of 96-microwell
plates, at a concentration of ;0.2 cell/microwell, in regular
DMEM containing 100 mg of BrdUrd and 50 mg of 8-azaadenine
per ml. Another portion of the fusion mixture (30 to ;100%, as
specified in Table II) was plated, either in one Petri dish or in
96-microwell plates (in general three), in special DMEM/galac-
tose medium containing BrdUrd and 8-azaadenine, and the
remainder was frozen.
Total cell DNA from 88 to 212 clones, isolated in different
experiments from a portion of the cell fusion mixture grown
under conditions non-selective for respiration competence (in
regular DMEM), was tested by restriction enzyme NaeI diges-
tion for the presence and proportion of the A8344G tRNALys
gene mutation in mtDNA. In three of the fusion mixtures
analyzed (experiments 3, 4, and 8 in Table II), a small fraction
of the clones tested showed the presence of the tRNALys gene
A8344G mutation in a proportion varying between 26 and 90%
of total mtDNA. Because of the apparent complete absence of
wild-type tRNALys genes in pT1.C3 cells and of wild-type ND4
genes in C4.13 cells (Fig. 3), in the clones which carried the
tRNALys gene mutation in a portion of their mtDNA, the re-
mainder of mtDNA was considered to represent mtDNA with
mutant ND4 genes. Accordingly, the percentage of clones with
mutant tRNALys genes provided an estimate of the frequency of
fusion of the two parental lines. This varied between 1.4 and
3.4% (Table II). In three of the fusion experiments, no clone
containing the tRNALys gene A8344G mutation was found, due
presumably to the very low frequency of cell fusion.
A few clones derived from the pT1.C3xC4.13 clone fusions,
which grew in galactose medium containing 8-azaadenine,
were analyzed for genotype (Fig. 3), chromosome number, ox-
ygen consumption rate (Table I), protein synthesis (Fig. 4), and
growth rate. All the clones tested contained both types of mu-
tant mtDNA, with the proportion of MERRF mutation-carrying
mtDNA varying between 60 and 82%, and with the two mutant
forms accounting, within 1–3%, for the totality of mtDNA (Fig.
3). These clones exhibited a chromosome number indicating
their cybrid nature, as expected from the recessive nature of
the APRTase null mutation, which would have killed any hy-
brid cell. Furthermore, they were fully respiratory-competent,
FIG. 3. Amounts of tRNALys gene or
ND4 gene mutation-carrying mt-
DNAs in the transcomplementing
clones derived from enC4T 3
recpT1.C3 and enpT1.C3 3 recC4.13
cell fusions. a and b, fluorograms, after
electrophoresis through a sequencing gel,
of the 32P-59-end-labeled primer extension
products obtained from samples of total
cellular DNA extracted from the indicated
cell lines. The relative proportions of the
two mutant mtDNAs in each cell line, es-
timated from the fluorograms, are shown
in Table I. WT, wild type; MT, mutant.
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as expected from the selection medium used (Table I). Their
protein synthesis patterns (Fig. 4) revealed the reacquisition of
the capacity to synthesize the ND5, ND4, and CYTb polypep-
tides and the strong reduction or absence of the abnormal
premature translation termination products pMERRF and
truncated ND2 polypeptide. In addition, they exhibited again a
preponderant labeling of the ND3 polypeptide characteristic of
pT1.C3 mtDNA (Fig. 4). As observed in the previous experi-
ments, the clones analyzed grew in general very slowly in
galactose medium (Table I) and exhibited a significant rate of
cell death (data not shown).
The evidence presented above indicated clearly that the
clones growing in galactose medium were true transcomple-
menting clones. As shown in Table II, the absolute
transcomplementation frequency among the clones isolated in
the experiments with high cell fusion frequency (experiments
3, 4, and 8) was similar to that previously observed for the
enC4T 3 pT1.C3 fusion (experiment 2), i.e. 5.4 and 8.4 3 1025
(experiments 3 and 4), or much higher (5.5 3 1024), in the case
of the fusion utilizing the largest excess of cytoplasts (experi-
ment 8). It was, on the contrary, considerably lower (1.2 to 3 3
1025) in the experiments with low cell fusion frequency (exper-
iments 5–7), as expected. The absolute frequency of the
transcomplementing clones, divided by the frequency of cell
fusion, provided an estimate of the relative efficiency of
transcomplementation. As shown in Table II, this varied be-
tween 3.0 3 1023 and 3.8 3 1023 in experiments 3 and 4, and
1.6 3 1022 in experiment 8. These results indicated clearly the
intrinsically very low frequency of the transcomplementation
events.
DISCUSSION
In the present work, large scale fusion experiments between
cultured human cell lines carrying two non-allelic recessive
mtDNA mutations have allowed the detection of stable
transcomplementation between the two mutations under
growth conditions selective for recovery of respiratory capacity.
However, the phenomenon occurred only very rarely among the
double transformants, with a 0.3 to 1.6% frequency, accounting
for the failure to detect it in earlier experiments not involving
selection for respiratory competence (18). The transcomple-
menting clones became established very sluggishly and exhib-
ited in general slow growth and a substantial rate of cell death.
The present results confirm the previous observations of
transcomplementation of mtDNA mutations in human cell cul-
tures (24, 25). However, they are in striking contrast to the
general model that has been proposed of human mitochondria
functioning as a single dynamic unit in a living cell, with rapid
diffusion of mtDNA and/or its products throughout the or-
ganelles (23). They support the conclusion that the capacity of
mitochondria to fuse and mix their genetic contents is not an
intrinsic general property of these organelles in mammalian
cells, although it may be susceptible to developmental and
physiological regulation.
Previously, the occurrence of apparent mitochondrial fusion
in mammalian cultured cells, independent of cell fusion, has
been reported by others (9, 10, 11) on the basis of studies using
optical or electron microscopy. Although fusion is necessary for
the occurrence of genetic complementation, any physical evi-
dence of fusion would not necessarily imply a mixing of the
mtDNAs and/or their products from different organelles. It is in
fact quite possible that only the external mitochondrial mem-
branes fuse or that the mtDNAs and their transcripts remain
compartmentalized in fully fused mitochondria.
Mechanism Underlying the Transcomplementation of the
Two Mutations—In the present work, one must assume that
some form of mitochondrial fusion event produced the observed
transcomplementation of the two mtDNA mutations analyzed.
However, nothing is known about the mechanism involved. The
very low frequency of reciprocal complementation of the two
mutations detected in the cytoplast or cell 3 cell fusion prod-
ucts argues strongly against a programmed phenomenon. One
cannot exclude that, in a small fraction of the transformed
recipient cells, a gene homologous to the fzo gene transiently
activated during spermatid development in D. melanogaster
(12) and to its equivalent found in S. cerevisiae (13, 14) and the
genes encoding other components of the mitochondrial fusion
FIG. 4. Fluorogram, after electro-
phoresis through an SDS-polyacryl-
amide gradient gel, of the mitochon-
drial translation products of the
indicated cell lines labeled with
[35S]methionine for 2 h in the pres-
ence of emetine. Symbols are as de-
scribed in the legend of Fig. 1.
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machinery (13) are expressed at a low level. However, a more
likely possibility, which has not been excluded in any of the
experiments reported so far in which transcomplementation
has been observed (23–25), is that the transient exposure of the
cells to polyethylene glycol (PEG) used to induce cell fusion
may be responsible for the fusion of mitochondria. The low
frequency of stable transcomplementing clones observed in the
present and previous work would imply that these mitochon-
drial fusion events, which would produce heteroplasmic or-
ganelles, would be followed by a reversal of transcomplemen-
tation, due to division of the organelles and re-segregation of
the two mtDNAs. According to this hypothesis, only very infre-
quently would transformants with stable intramitochondrial
heteroplasmy be selected, accounting for the great rarity of
stable transcomplementing clones observed. A similar hypoth-
esis had been previously proposed, which associated mitochon-
drial fusion with a transient response to a cell fusion stimulus,
like during myotube formation (45). One may further elaborate
this alternative model by assuming that the transient response
to a cell fusion stimulus would involve an activation of the fzo
gene and related genes. If an extensive reversible mitochondrial
fusion event during cell fusion does indeed occur, the real in
vivo frequency of transcomplementation events may be much
lower than observed here. This possibility is open to experi-
mental test through the introduction of donor mitochondria
into the recipient cell by microinjection (46).
Factors Affecting the Efficiency of Transcomplementa-
tion—In the scenario discussed above of mitochondrial fusion
being transiently activated during cell fusion, the very rare,
slowly established transcomplementing clones detected in this
work and previously by others (24, 25) would represent those
few clones that underwent no segregation or only partial inter-
mitochondrial segregation of the two mutant mtDNAs. The
considerable proportion of dead cells that was observed in the
present work during growth of the surviving clones after cell
fusion may well be the result of an equilibrium situation be-
tween selection of cells having reached the threshold of respi-
ratory competence associated with the minimum necessary
number of heteroplasmic organelles and continuous loss of this
competence due to segregation of the two defective mtDNAs by
mitochondrial division.
It has been suggested that the very low frequency of
transcomplementation between homoplasmic recessive
mtDNA mutations in cell fusion products grown under condi-
tions selective for respiration may result from lack of produc-
tion of sufficient energy to overcome the energy barrier of
membrane fusion (25). However, this suggestion is not sup-
ported by the results of previously mentioned work from this
laboratory (18), which had shown that the non-transcomple-
menting clones isolated under conditions non-selective for res-
piration grew at a high rate (doubling times between 22 and
28 h) and were presumably able to produce adequate ATP from
glycolysis to carry out mitochondrial fusions. In the present
work, the possibility that the observed very low frequency of
transcomplementation was due to the fact that the incubation
of the cell fusion products under non-selective conditions was
too short to allow adequate mitochondrial fusion, and genetic
complementation is not supported by the available evidence. In
fact, in the first experiment, a 2-day and a 6-day incubation of
the fusion products under non-selective conditions yielded
about the same number of clones surviving under selective
pressure. Furthermore, an argument against the idea of a
quick death of respiratory-deficient cells in selective medium is
the observation that the proportion of dead cells after a 2-day
incubation in such medium of the two parental cell lines was
only 12–40%. Finally, the observation that, in ND4 gene frame-
shift mutation-carrying mitochondria, all proteins other than
ND4 exhibited a normal rate of synthesis and the expectation
that these organelles carried an ;2-fold excess of aminoacy-
lated tRNALys over that required to support normal translation
(35) strongly suggests that, if they underwent a fusion with
tRNALys mutation-carrying mitochondria, there would be a
rapid complementation of the latter mutation.
The finding in the present work that, independently of
whether tRNALys gene mutation- or ND4 gene mutation-car-
rying cells were used as recipients for cell fusion, the MERRF
mutation-carrying mtDNA was always predominant (60–90%
in the various complementing clones) presumably reflected the
need for the cell to have an adequate rate of NADH dehydro-
genase activity. It is known, in fact, that Complex I-dependent
O2 consumption is usually the rate-limiting step in respiration
(47, 48).
Implications for Disease-causing or Aging-related mtDNA
Mutations—The present observations have important implica-
tions for understanding the segregation and complementation
behavior of disease-causing mtDNA mutations in man and the
transmission of such diseases (49), as well as for potential
therapeutic approaches involving mitochondria-mediated gene
transfer. Another area where the observed tendency of mam-
malian mitochondria to remain genetically autonomous has
significant implications is that of aging-dependent mtDNA
damage. There is substantial evidence of an aging-related oc-
currence in mtDNA of oxidative derivatives of nucleotides (50),
of small deletions and insertions, and of large deletions (51–
54). Most significantly, very recently an aging-dependent large
accumulation of specific mutations in a critical control region
for mtDNA replication has been demonstrated in human fibro-
blasts (55). The functional effects of these mutations depend
not only on their frequency but also on whether or not mito-
chondria can fuse and mix their mtDNA products, so as to allow
wild-type genes to complement mutant genes. Additivity of the
aging-dependent dysfunctions of the individual organelles in a
cell, as opposed to transcomplementation between mitochon-
dria, would magnify considerably the overall damage to the
cell.
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